Clinical Trial Update: Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose Tolerance [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the metabolic effects of metformin in obese, insulin-resistant adolescents with normal glucose tolerance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperinsulinemia
• Insulin Resistance
• Obesity in Children

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Yale University | Conditions: Pediatric Obesity, Insulin Resistance | Phase 4 | Status: COMPLETED